Indirect Down-regulation of Tumor-suppressive let-7 Family MicroRNAs by LMO1 in Neuroblastoma

Cancer Genomics Proteomics. 2018 Sep-Oct;15(5):413-420. doi: 10.21873/cgp.20100.

Abstract

Background/aim: Overall survival for the high-risk group of neuroblastoma (NB) patients still remains at 40-50%, necessitating the establishment of a curable treatment. LIM domain only 1 (LMO1) gene encoding a transcriptional regulator is an NB-susceptibility gene with a tumor-promoting activity. Previously we conducted chromatin immunoprecipitation and DNA sequencing analyses on NB cell lines and identified 3 protein-coding genes regulated by LMO1. In this study, we extended our analyses to capture microRNA genes directly or indirectly regulated by LMO1.

Materials and methods: Using microarrays, we conducted a comparative gene expression analysis on an NB cell line SK-N-SH; between the cells with and without LMO1 suppression.

Results: Overall, 18 microRNAs were identified to be indirectly down-regulated by LMO1 including 7 microRNAs of the let-7 family, whose cell proliferation inhibitory activity was observed.

Conclusion: Target genes of the LMO1-regulated microRNAs and their relevant pathways may be a potential therapeutic target.

Keywords: LMO1; Neuroblastoma; let-7; microRNA; pediatric cancer.

MeSH terms

  • Cell Line, Tumor
  • Cell Proliferation / genetics
  • DNA-Binding Proteins / genetics*
  • Gene Expression Regulation / genetics
  • Humans
  • LIM Domain Proteins / genetics*
  • MicroRNAs / genetics*
  • Microarray Analysis / methods
  • Neuroblastoma / genetics*
  • Neuroblastoma / pathology
  • Transcription Factors / genetics*

Substances

  • DNA-Binding Proteins
  • LIM Domain Proteins
  • LMO1 protein, human
  • MicroRNAs
  • Transcription Factors
  • mirnlet7 microRNA, human